Unicharm (8113) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Jun, 2025Executive summary
Q1 FY2025 consolidated sales were 227.5 billion yen, down 3.7% year-over-year, with core operating profit at 29 billion yen, down 22.7%, mainly due to last year's high base and increased marketing investments.
Profit attributable to owners of parent increased 39.7% to 24.9 billion yen, supported by insurance income and other factors.
The operating environment remained challenging overseas due to economic uncertainty and competition, while domestic sales in Japan stayed strong, driven by demand for daily necessities and value-shifting in personal care.
Overseas sales declined 7.1% and profit dropped 42.5%, with Asia impacted by negative publicity in China and slow baby care in Indonesia, but North America and the Middle East exceeded expectations.
Annual dividend increased for the 24th consecutive year, with a buyback of approx. 12 billion yen in shares as of April 2025.
Financial highlights
Net sales: 227.5 billion yen (down 3.7% YoY); core operating profit: 29 billion yen (down 22.7% YoY).
Profit attributable to owners of parent: 24.9 billion yen (up 39.7% YoY); EPS: 14.18 yen (up 40.8% YoY), reflecting a 3-for-1 stock split.
EBITDA: 47.0 billion yen (up 2.4% YoY).
Gross profit margin deteriorated by 0.1 percentage points to 38.9%; sales and administrative expense rate worsened by 3.0 percentage points.
Cash and cash equivalents increased to 287.8 billion yen, up 26.7 billion yen from year-end.
Outlook and guidance
FY2025 sales forecast: 1,025 billion yen (+3.6% YoY); core operating profit: 146 billion yen (+5.4% YoY); net profit attributable to owners of parent: 86.4 billion yen (+5.5% YoY).
Q2 is expected to see sales growth with flat operating profit YoY; over 20% operating profit growth targeted in the second half.
Dividend forecast for FY2025 is 18 yen per share post-stock split.
Strategic investments in Asia expected to drive recovery in core operating profit from Q2 onward.
Proactive investment in feminine, wellness, and pet care segments in Asia; new product launches and e-commerce expansion planned in China.
Latest events from Unicharm
- Profits fell in FY2025, but FY2026 forecasts strong recovery and higher dividends.8113
Q4 202512 Feb 2026 - Sales and core profit declined, but profit attributable to owners rose 2.0% YoY.8113
Q3 20257 Nov 2025 - Sales and profits fell, but resilient regions and cost controls support a recovery outlook.8113
Q2 20255 Aug 2025 - Record sales and profit growth continue, with strong overseas and segment performance.8113
Q2 202413 Jun 2025 - Record sales and profit growth, with strong personal and pet care and rising dividends.8113
Q3 202413 Jun 2025 - Record sales and profit growth, with a stock split and strong FY2025 outlook.8113
Q4 20245 Jun 2025